Author

F. Jia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:differential expression· 1 Research Focus:protein structure prediction· 1 Organism:rat· 1

Frequent Co-Authors

C. Gu· 2 shared K. Xia· 2 shared P. Liu· 2 shared S.-J. Deng· 2 shared X. Cao· 2 shared X. Liu· 2 shared X. Wang· 2 shared Y. Xu· 2 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiophysics

C. Gu

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody: mechanisms for the high infectivity, immune evasion and antibody drug discovery

W. Yin, Y. Xu, P. Xu, X. Cao, C. Wu, C. Gu, X. He, X. Wang, S. Huang, Q. Yuan, K. Wu, W. Hu, Z. Huang, J. Liu, Z. Wang, , H. E. Xu

bioRxiv · Dec 27, 2021 · PreprintBiophysics

A human antibody with blocking activity to RBD proteins of multiple SARS-CoV-2 variants including B.1.351 showed potent prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus macaques

C. Gu, X. cao, Z. Wang, X. Hu, Y. Yao, Y. Zhou, P. Liu, X. Liu, G. Gao, X. Hu, H. Liang, Z. Chen, L. Gao, Y. Peng, F. Jia, , S.-J. Deng

bioRxiv · Feb 7, 2021 · PreprintMicrobiology

Genome-Wide Mapping of Cisplatin Damaged Gene Loci

L. Qi, Q. Luo, Y. Xu, W. Yu, X. Liu, Y. Zhang, F. Jia, T. Fang, S. Wang, X. Li, Y. Zhao, F. Wang

This study maps cisplatin-damaged gene loci and identifies key pathways and targets, revealing SPAG9 as a potential therapeutic target for testicular cancer.

bioRxiv · Jul 27, 2020 · PreprintPharmacology & Toxicology